Tislelizumab
BGB-A317-314
Phase 3 small_molecule terminated
Quick answer
Tislelizumab for Classical Hodgkin Lymphoma is a Phase 3 program (small_molecule) at BeOne Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BeOne Medicines
- Indication
- Classical Hodgkin Lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated